AEGiS-UNAIDS: Results of recent population-based surveys UNAIDSImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to UNAIDS main menu
DonateNow
Print this Article


Results of recent population-based surveys

UNAIDS - July 6, 2007


1. How have results of population-based surveys been used in refining AIDS estimates?

Since 2000 several countries have conducted nationally representative population-based surveys with HIV prevalence measurement. The first ones were conducted in Mali and Zambia in 2001-2002. By mid 2007 a total of 26 countries in sub-Saharan Africa had conducted surveys. In addition the two countries in the Caribbean with the largest HIV burden, Haiti and the Dominican Republic, as well as India and Cambodia in Asia had also conducted population-based surveys.

The information from available surveys has helped to refine UNAIDS published estimates. Where surveys were available prior to the publication of each of the UNAIDS biannual Global Report, the prevalence estimates from the survey have been used to inform the estimates in the UNAIDS Global Reports and consequently the two are very close to each other. As shown in the attached Table, all but one of these surveys (Uganda) has shown a lower prevalence in the survey compared to previously published estimates based on sentinel surveillance data.

The results of a number of surveys however have become available after the 2006 UNAIDS Global Report. Most of these have already been incorporated in the regional estimates published in the 2006 AIDS Epidemic Update, notably Cote d'Ivoire, Cambodia and Haiti. It is noteworthy that the recent survey in the Central African Republic showed a prevalence of 6.2% in 2006 compared to the published estimate of 10.7% for 2005. In other countries in sub-Saharan Africa recent estimates from the population based surveys are close to previously published estimates (Benin, Mali (2006), Niger (2006), Zimbabwe). In Asia, besides India, a population-based survey has also been conducted in Cambodia, suggesting a lower prevalence (0.6% in 2005) than previously estimated (1.6% in 2005).

2. Where can we expect significant differences in the results of population-based surveys and AIDS estimates?

Population-based surveys with HIV prevalence measurement are currently planned or ongoing in several countries in sub-Saharan Africa including the Democratic Republic of Congo, Eritrea, Gabon, Gambia, Liberia and Madagascar. There are no population-based surveys planned in other countries outside of sub-Saharan Africa, as most countries have low prevalence and would not benefit from this type of survey.

3. What is the impact of the differences in the results of population-based surveys and AIDS estimates?

According to the 2006 AIDS Epidemic Update report, the estimated number of people living with HIV in 2006 was 39.5 million people (range 34.1 - 47.1 million). Although several countries report lower prevalence, the total number is still well within the estimated global range for 2006 and remains large.

Cambodia was previously estimated to have 130,000 people living with HIV (range 74,000-210,000). Any changes in Cambodia's estimates would therefore only have a minor impact on regional and global estimates. In sub-Saharan Africa too, it is expected that the new figures will only have a minor impact on regional prevalence (currently estimated at 5.9% (24.7 million)) and are well within the regional range (5.2% - 6.7% (21.8 - 27.7 million)).


070706
UN070706


Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .